Advertisement
Screener

Tengjun Biotechnology Corp. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

Tengjun Biotechnology Corp. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

Tengjun Biotechnology Corp. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$466.70 thousand for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-15.

Discontinued › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2023-08-15

  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was -$466.70K, a 111.29% decline year-over-year.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-03-31 was $390.59K, a 67.77% increase year-over-year.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-12-31 was $3.99M.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2022-09-30 was $3.61M.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was $11.97M.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$747.52K.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$690.89K.
  • Tengjun Biotechnology Corp. net income (loss), including portion attributable to noncontrolling interest for fiscal 2013 was -$21.31K.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month as first filedNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 15 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 18 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 21 month
2023-06-30-$466.70K
10-Q · filed 2023-08-15
-$76.11K
10-Q · filed 2023-08-15
$3.91M
derived: sum of 3 quarters · filed 2023-08-15
$7.53M
derived: sum of 4 quarters · filed 2023-08-15
2023-03-31$390.59K
10-Q · filed 2023-08-15
$4.38M
derived: sum of 2 quarters · filed 2023-08-15
$8.00M
derived: sum of 3 quarters · filed 2023-08-15
$12.13M
derived: sum of 4 quarters · filed 2023-08-15
2022-12-31$3.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
$7.61M
derived: sum of 2 quarters · filed 2023-04-17
$11.74M
derived: sum of 3 quarters · filed 2023-08-15
$11.97M
10-K · filed 2023-04-17
2022-09-30$3.61M
10-Q · filed 2022-11-14
$7.75M
derived: sum of 2 quarters · filed 2023-08-15
$7.98M
10-Q · filed 2022-11-14
$7.73M
derived: sum of 4 quarters · filed 2023-08-15
2022-06-30$4.13M
10-Q · filed 2023-08-15
-$3.43M
10-Q · filed 2022-08-15
$4.37M
10-Q · filed 2023-08-15
-$3.20M
10-Q · filed 2022-08-15
$4.11M
derived: sum of 3 quarters · filed 2023-08-15
$4.01M
derived: sum of 4 quarters · filed 2023-08-15
2022-03-31$232.81K
10-Q · filed 2023-08-15
-$19.24K
derived: sum of 2 quarters · filed 2023-08-15
-$126.54K
derived: sum of 3 quarters · filed 2023-08-15
-$348.62K
derived: sum of 4 quarters · filed 2023-08-15
2021-12-31-$252.04K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-17
-$359.35K
derived: sum of 2 quarters · filed 2023-04-17
-$581.43K
derived: sum of 3 quarters · filed 2023-04-17
-$747.52K
10-K · filed 2023-04-17
2021-09-30-$107.30K
10-Q · filed 2022-11-14
-$15.47K
10-Q · filed 2021-10-20
-$329.38K
derived: sum of 2 quarters · filed 2022-11-14
-$495.48K
10-Q · filed 2022-11-14
2021-06-30-$222.08K
10-Q · filed 2022-11-14
-$15.68K
10-Q · filed 2021-07-20
-$388.18K
10-Q/A · filed 2022-09-16
2021-03-31-$166.10K
10-Q · filed 2022-11-14
-$16.80K
10-Q · filed 2021-07-20
2020-12-31-$690.89K
10-K · filed 2022-03-31
2020-09-30-$11.96K
10-Q · filed 2021-10-20
-$24.86K
derived: sum of 2 quarters · filed 2021-10-20
-$41.65K
derived: sum of 3 quarters · filed 2021-10-20
2020-06-30-$12.90K
10-Q · filed 2021-10-20
-$29.69K
derived: sum of 2 quarters · filed 2021-10-20
2020-03-31-$16.79K
10-Q · filed 2021-10-20
2013-12-31-$21.31K
10-K · filed 2014-04-09
2012-12-31-$34.17K
10-K · filed 2014-04-09
2012-03-31-$18.06K
10-Q · filed 2012-04-19
-$19.01K
derived: sum of 2 quarters · filed 2012-04-19
-$86.81K
10-Q · filed 2012-04-19
2011-12-31-$953.00
derived: 10-K 18 month − 10-Q 15 month · filed 2012-02-23
-$24.76K
10-K · filed 2014-04-09
-$68.75K
10-K · filed 2012-02-23
2011-09-30-$23.80K
10-Q · filed 2011-10-19
-$67.80K
10-Q · filed 2011-10-19
2011-03-31-$11.26K
10-Q · filed 2012-04-19
-$30.79K
derived: sum of 2 quarters · filed 2014-04-09
-$55.26K
derived: sum of 3 quarters · filed 2014-04-09
2010-12-31-$19.53K
derived: 10-K 6 month − 10-Q 3 month · filed 2014-04-09
-$43.99K
10-K · filed 2014-04-09
2010-09-30-$24.46K
10-Q · filed 2011-10-19